
ACC/WCC 2020

Read the full Report (pdf)
ACC.20/WCC Virtual Meeting American College of Cardiology; 28-30 March 2020
Featured articles


ACC.20/WCC Highlights Podcast Part 1 of 3

ACC.20/WCC Highlights Podcast Part 2 of 3
CONTENTS
Online First
Heart Failure and Cardiomyopathies
Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy

Vericiguat shows beneficial effects in a very high-risk HF population
No role for sodium nitrite in out-of-hospital cardiac arrest
Vascular Medicine and Thromboembolism

Rivaroxaban and aspirin effective and safe for PAD patients
Subgroup analysis VOYAGER PAD
TAILOR-PCI misses endpoint but still provides valuable insights

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?
Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

Apixaban offers new perspective for cancer patients in need of anticoagulation
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Interventional Cardiology
TAVR safe and effective in low-risk bicuspid aortic stenosis patients
TAVR model reveals differences in hospital outcomes
TAVR versus surgery in older patients
Real-world evidence for MitraClip
2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
